About RNAGENE
RNAGENE is a company based in Seoul (South Korea) founded in 2020. It operates as a B2B. RNAGENE offers products and services including mRNA Synthesis Service and Customized mRNA-LNP Formulation. RNAGENE operates in a competitive market with competitors including Jazz Pharmaceuticals, Adaptive Biotechnologies, Moderna, C4 Therapeutics and Erasca, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RNAGENE
RNAGENE offers a comprehensive portfolio of products and services, including mRNA Synthesis Service and Customized mRNA-LNP Formulation.
Provides customized mRNA synthesis for vaccines and therapies
Offers formulation services for mRNA-based products and applications
Funding Insights of RNAGENE
Detailed funding history for RNAGENE
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RNAGENE
Investment portfolio details for RNAGENE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RNAGENE
Detailed financials for RNAGENE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rnagene Comparisons
Peer comparison for RNAGENE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RNAGENE
RNAGENE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Adaptive Biotechnologies, Moderna, C4 Therapeutics and Erasca, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
Detailed competitors of RNAGENE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rnagene
Complete news archive for RNAGENE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RNAGENE
RNAGENE was founded in 2020.
RNAGENE is headquartered in Seoul, South Korea.
RNAGENE is a biotechnology company specializing in mRNA technology for developing vaccines and therapies. They provide customized mRNA synthesis services and formulations, focusing on areas like prophylactic vaccines, rare diseases, and cancer immunotherapy. Based in Seoul, South Korea, they conduct RD collaborations to address global health needs through innovative research and partnerships.
RNAGENE's top competitors include Moderna, Jazz Pharmaceuticals and C4 Therapeutics.
RNAGENE offers mRNA Synthesis Service and Customized mRNA-LNP Formulation.